PYMNTS
04 Sept 2026, 19:33 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
GoodRx reported a 12% decline in its traditional monthly active consumer base to 5 million in Q2. — A double-digit drop in the core user base is a significant negative indicator of organic growth and platform relevance.
-0.40GoodRx is expanding its Companion subscription to a Family Plan covering up to four dependents, including pets. — Diversifying the product offering to a household model increases the potential Total Addressable Market (TAM) and customer stickiness.
+0.30GoodRx will offer the Companion plan through 'Employer Direct,' allowing companies to subsidize memberships for employees. — Entering the B2B employer channel creates a high-volume acquisition funnel and a more stable, recurring revenue stream.
+0.30Continue reading
6 related stories
Top 3 movers · tap to explore
GoodRx Q2 revenue declined 1% to $200.4 million. — Stagnant top-line growth suggests the company is struggling to monetize its current user base effectively.
-0.20Which stocks this story touches
The company launched a new family subscription plan to expand its customer base, though this follows recent revenue and active user declines.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
41m ago
